Document is current
Any future updates will be listed below
-
Authors
Wang, Tong https://orcid.org/0000-0003-4208-5578
Fowler, Johanna M. https://orcid.org/0000-0003-2248-2947
Liu, Laura https://orcid.org/0000-0003-3120-149X
Loo, Christian E. https://orcid.org/0000-0002-7060-3558
Luo, Meiqi https://orcid.org/0000-0002-8063-0250
Schutsky, Emily K. https://orcid.org/0000-0003-4885-6353
Berríos, Kiara N. https://orcid.org/0000-0002-0684-5413
DeNizio, Jamie E.
Dvorak, Ashley
Downey, Nick
Montermoso, Saira https://orcid.org/0000-0002-8494-9162
Pingul, Bianca Y.
Nasrallah, MacLean
Gosal, Walraj S.
Wu, Hao
Kohli, Rahul M. https://orcid.org/0000-0002-7689-5678
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG-012892, R01-HG10646, R01-HG10646)
NSF GRFP
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM07729)
NSF | Directorate for Education & Human Resources | Division of Graduate Education (DGE-1321851)
- License Information
-
More Information
Article History
Received: 7 June 2022
Accepted: 17 March 2023
First Online: 15 June 2023
Competing interests
: The University of Pennsylvania has patents pending for CxMTase enzymes, DNA deaminase-resistant adapters and the DM-Seq pipeline. R.M.K. has served as a scientific advisory board member for Cambridge Epigenetix (CEGX). W.S.G. is an employee of CEGX and T.W. was supported by a fellowship from CEGX. A.D. and N.D. are employees of Integrated DNA Technologies, Inc. The other authors declare no competing interests.
